Two sections of the guideline, HPV oncogenic types not 16/18 and Self-collected vaginal samples have been reviewed and updated. Updated guidance came into effect on 1 February 2021.
For further information, see: Review of National Cervical Screening Program data and partial update.
To be notified about the launch of updated guideline content, contact guidelines(at)cancer.org.au.
Clinical management guidelines for the prevention of cervical cancer
Foreword
Introduction
Summary of recommendations
1. Cervical cancer in Australia
2. The rationale for primary HPV screening
3. Terminology
4. Unsatisfactory cervical screening results
5. Benefits, harms and cost-effectiveness of cervical screening
6. Management of oncogenic HPV test results
7. Colposcopy
8. Management of discordant colposcopic impression, histopathology and referral LBC prediction
9. Management of histologically confirmed low-grade squamous abnormalities
10. Management of histologically confirmed high-grade squamous abnormalities
11. Management of glandular abnormalities
12. Screening in Aboriginal and Torres Strait Islander women
13. Screening after total hysterectomy
14. Screening in pregnancy
15. Screening in women who have experienced early sexual activity or have been victims of sexual abuse
16. Screening in immune-deficient women
17. Screening in DES-exposed women
18. Signs and symptoms of cervical cancer
19. Psychosocial care
20. Transition to the renewed National Cervical Screening Program
Appendices
- A. Modelled evaluation of the predicted benefits, harms and cost-effectiveness of the renewed National Cervical Screening Program (NCSP) in conjunction with these guideline recommendations
- B. Guidelines development process
- C. Clinical question list
- D. Technical report
- E. & F. Working party members and contributors
- G. Conflict of interest register
- H. Safety monitoring of the Renewed cervical screening program
- I. Glossary (terms and abbreviations)
Please see the Australian Department of Health Cancer Screening website for information about the National Cervical Screening Program (NCSPNational Cervical Screening ProgramA joint program of the Australian, state and territory governments. It aims to reduce morbidity and mortality from cervical cancer, in a cost-effective manner through an organised approach to cervical screening. The program encourages women in the target population to have regular Pap smears.) and policies on transitioning women to the renewed NCSPNational Cervical Screening ProgramA joint program of the Australian, state and territory governments. It aims to reduce morbidity and mortality from cervical cancer, in a cost-effective manner through an organised approach to cervical screening. The program encourages women in the target population to have regular Pap smears..
Resources
Cervical cancer screening online education modules (e-learning)
Social links